Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes

Myeloid-derived suppressor cells (MDSC) contribute to an immunosuppressive network that drives cancer escape by disabling T cell adaptive immunity. The prevailing view is that MDSC-mediated immunosuppression is restricted to tissues where MDSC co-mingle with T cells. Here we show that splenic or, un...

Full description

Bibliographic Details
Main Authors: Amy W Ku, Jason B Muhitch, Colin A Powers, Michael Diehl, Minhyung Kim, Daniel T Fisher, Anand P Sharda, Virginia K Clements, Kieran O'Loughlin, Hans Minderman, Michelle N Messmer, Jing Ma, Joseph J Skitzki, Douglas A Steeber, Bruce Walcheck, Suzanne Ostrand-Rosenberg, Scott I Abrams, Sharon S Evans
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2016-12-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/17375
_version_ 1811180399720660992
author Amy W Ku
Jason B Muhitch
Colin A Powers
Michael Diehl
Minhyung Kim
Daniel T Fisher
Anand P Sharda
Virginia K Clements
Kieran O'Loughlin
Hans Minderman
Michelle N Messmer
Jing Ma
Joseph J Skitzki
Douglas A Steeber
Bruce Walcheck
Suzanne Ostrand-Rosenberg
Scott I Abrams
Sharon S Evans
author_facet Amy W Ku
Jason B Muhitch
Colin A Powers
Michael Diehl
Minhyung Kim
Daniel T Fisher
Anand P Sharda
Virginia K Clements
Kieran O'Loughlin
Hans Minderman
Michelle N Messmer
Jing Ma
Joseph J Skitzki
Douglas A Steeber
Bruce Walcheck
Suzanne Ostrand-Rosenberg
Scott I Abrams
Sharon S Evans
author_sort Amy W Ku
collection DOAJ
description Myeloid-derived suppressor cells (MDSC) contribute to an immunosuppressive network that drives cancer escape by disabling T cell adaptive immunity. The prevailing view is that MDSC-mediated immunosuppression is restricted to tissues where MDSC co-mingle with T cells. Here we show that splenic or, unexpectedly, blood-borne MDSC execute far-reaching immune suppression by reducing expression of the L-selectin lymph node (LN) homing receptor on naïve T and B cells. MDSC-induced L-selectin loss occurs through a contact-dependent, post-transcriptional mechanism that is independent of the major L-selectin sheddase, ADAM17, but results in significant elevation of circulating L-selectin in tumor-bearing mice. Even moderate deficits in L-selectin expression disrupt T cell trafficking to distant LN. Furthermore, T cells preconditioned by MDSC have diminished responses to subsequent antigen exposure, which in conjunction with reduced trafficking, severely restricts antigen-driven expansion in widely-dispersed LN. These results establish novel mechanisms for MDSC-mediated immunosuppression that have unanticipated implications for systemic cancer immunity.
first_indexed 2024-04-11T09:01:30Z
format Article
id doaj.art-3703c01018fe4546bf5280e8e6082a72
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-11T09:01:30Z
publishDate 2016-12-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-3703c01018fe4546bf5280e8e6082a722022-12-22T04:32:45ZengeLife Sciences Publications LtdeLife2050-084X2016-12-01510.7554/eLife.17375Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodesAmy W Ku0Jason B Muhitch1Colin A Powers2Michael Diehl3Minhyung Kim4Daniel T Fisher5Anand P Sharda6Virginia K Clements7Kieran O'Loughlin8Hans Minderman9Michelle N Messmer10Jing Ma11Joseph J Skitzki12Douglas A Steeber13Bruce Walcheck14Suzanne Ostrand-Rosenberg15Scott I Abrams16Sharon S Evans17https://orcid.org/0000-0003-2958-6642Department of Immunology, Roswell Park Cancer Institute, Buffalo, United StatesDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, United States; Department of Urology, Roswell Park Cancer Institute, Buffalo, United StatesDepartment of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, United StatesDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, United StatesDepartment of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, United StatesDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, United States; Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, United StatesDepartment of Urology, Roswell Park Cancer Institute, Buffalo, United StatesDepartment of Biological Sciences, University of Maryland Baltimore County, Baltimore, United StatesFlow and Image Cytometry, Roswell Park Cancer Institute, Buffalo, United StatesFlow and Image Cytometry, Roswell Park Cancer Institute, Buffalo, United StatesDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, United StatesDepartment of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, United StatesDepartment of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, United StatesDepartment of Biological Sciences, University of Wisconsin-Milwaukee, Milwaukee, United StatesDepartment of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, United StatesDepartment of Biological Sciences, University of Maryland Baltimore County, Baltimore, United StatesDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, United StatesDepartment of Immunology, Roswell Park Cancer Institute, Buffalo, United StatesMyeloid-derived suppressor cells (MDSC) contribute to an immunosuppressive network that drives cancer escape by disabling T cell adaptive immunity. The prevailing view is that MDSC-mediated immunosuppression is restricted to tissues where MDSC co-mingle with T cells. Here we show that splenic or, unexpectedly, blood-borne MDSC execute far-reaching immune suppression by reducing expression of the L-selectin lymph node (LN) homing receptor on naïve T and B cells. MDSC-induced L-selectin loss occurs through a contact-dependent, post-transcriptional mechanism that is independent of the major L-selectin sheddase, ADAM17, but results in significant elevation of circulating L-selectin in tumor-bearing mice. Even moderate deficits in L-selectin expression disrupt T cell trafficking to distant LN. Furthermore, T cells preconditioned by MDSC have diminished responses to subsequent antigen exposure, which in conjunction with reduced trafficking, severely restricts antigen-driven expansion in widely-dispersed LN. These results establish novel mechanisms for MDSC-mediated immunosuppression that have unanticipated implications for systemic cancer immunity.https://elifesciences.org/articles/17375myeloid-derived suppressor cellsT cell traffickinglymph nodeL-selectin
spellingShingle Amy W Ku
Jason B Muhitch
Colin A Powers
Michael Diehl
Minhyung Kim
Daniel T Fisher
Anand P Sharda
Virginia K Clements
Kieran O'Loughlin
Hans Minderman
Michelle N Messmer
Jing Ma
Joseph J Skitzki
Douglas A Steeber
Bruce Walcheck
Suzanne Ostrand-Rosenberg
Scott I Abrams
Sharon S Evans
Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes
eLife
myeloid-derived suppressor cells
T cell trafficking
lymph node
L-selectin
title Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes
title_full Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes
title_fullStr Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes
title_full_unstemmed Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes
title_short Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes
title_sort tumor induced mdsc act via remote control to inhibit l selectin dependent adaptive immunity in lymph nodes
topic myeloid-derived suppressor cells
T cell trafficking
lymph node
L-selectin
url https://elifesciences.org/articles/17375
work_keys_str_mv AT amywku tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT jasonbmuhitch tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT colinapowers tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT michaeldiehl tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT minhyungkim tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT danieltfisher tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT anandpsharda tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT virginiakclements tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT kieranoloughlin tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT hansminderman tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT michellenmessmer tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT jingma tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT josephjskitzki tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT douglasasteeber tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT brucewalcheck tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT suzanneostrandrosenberg tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT scottiabrams tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes
AT sharonsevans tumorinducedmdscactviaremotecontroltoinhibitlselectindependentadaptiveimmunityinlymphnodes